Published on:

Antidepressant drug gets new warnings

New drug safety warnings have been added to the Norpramin label. Norpramin is an antidepressant drug. The new label describes potentially fatal side effects in patients with a family history of certain cardiac health conditions. The drug’s manufacturer is Sanofi-Aventis and they said that the new label also includes new language on overdosage.

Neither the drug manufacturer nor the Food and Drug Administration (FDA), which also issued its own notice of the revisions, explained what prompted the new warnings on the antidepressant drugs. The label will also warn about seizures that precede abnormal heart rhythms and death in some cases.

The attorneys at Levin & Perconti think that it is very important to be cognizant of warning labels on antidepressant medications. Recently, we learned that the number of Americans on antidepressants have doubled in the last decade. Nonetheless, a recent study also reported a correlation between a persistent decline in the rate of Americans newly diagnosed with depression and the warnings on antidepressant medications. In 2003, the FDA first warned about the risk of suicidal thoughts, which may have helped reverse a five year trend of rising rates of depression diagnosis.

To learn more about the new drug safety warnings.